Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETDRS
NCT00000151Phase 3Completed
- Sponsor
- National Eye Institute
- Start
- Dec 1979
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised trial of aspirin in diabetic retinopathy (DR) (3 arms), sponsored by National Eye Institute. Primary endpoint: Progression to severe stages of visual loss and blindness at 4 years. Started Dec 1979; status: completed.
02
Drugs
aspirin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT00000151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000151.